Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Clin Geriatr Med. 2013 Aug;29(3):641-55. doi: 10.1016/j.cger.2013.05.004.
Because the fastest-growing group of patients undergoing dialysis is older than 75 years, geriatricians will be more involved in decisions regarding the appropriate treatment of end-stage renal disease. A thoughtful approach to shared decision making regarding dialysis or nondialysis medical therapy (NDMT) includes consideration of medical indications, patient preferences, quality of life, and contextual features. Determination of prognosis and expected performance on dialysis based on disease trajectories and assessment of functional age should be shared with patients and families. The Renal Physician Association's guidelines on shared decision making in dialysis offer recommendations to help with dialysis or NDMT decisions.
由于接受透析治疗的患者中增长最快的群体年龄超过 75 岁,老年病医生将更多地参与有关终末期肾脏疾病的适当治疗决策。在关于透析或非透析治疗(NDMT)的共同决策中,应考虑医疗指征、患者偏好、生活质量和环境特征,采取深思熟虑的方法。应与患者和家属共同确定基于疾病轨迹的预后和透析预期表现,并评估功能年龄。肾脏医师协会关于透析共同决策的指南提供了一些建议,以帮助做出透析或 NDMT 决策。